Please provide your email address to receive an email when new articles are posted on . Women with atherosclerotic heart disease were less likely than men to receive a statin prescription. Women were ...

TUESDAY, Sept. 19, 2023 (HealthDay News) -- Among patients with atherosclerotic cardiovascular disease (ASCVD), high-intensity statins are underutilized in routine care, according to a study published ...

More than one in four patients in the United States with atherosclerotic cardiovascular disease (ASCVD) are not on a guideline-recommended statin or other lipid-lowering therapy, with suboptimal ...

Choices for pharmacologic therapy should be guided by a 10-year global risk assessment score for ASCVD or coronary heart disease using established risk equations (eg, the Framingham risk calculator, ...

Patients with established clinical ASCVD Patients with severe primary hypercholesterolemia (a baseline LDL-C level ≥190 mg/dL) Patients 40-75 years of age with diabetes and a baseline LDL-C level of ...

Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...

NEW ORLEANS, LA—Ever since statin guidelines were revised to urge physicians to prescribe high-intensity statins rather than treating to a specific LDL target, the debate has continued: is the “fire ...

NEW ORLEANS -- It was inflammation, not cholesterol per se, that was the bigger contributor to residual cardiovascular risk on statin therapy, according to a large meta-analysis of the PROMINENT, ...

Using cholesterol-lowering medications more intensively to achieve a more aggressive target for low-density lipoprotein cholesterol (LDL-C) reduced the rate of major cardiovascular events by one-third ...